Drug Topics

JANUARY 20, 2023

The PDUFA date has been set for May 22, 2023.

FDA 468

FDA 468

Pharmaceutical Technology

JANUARY 20, 2023

Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution. Whether it’s soaring temperatures, extreme cold snaps, or devastating floods, pharmaceutical logistics providers must ensure that shipments reach their destination in their intended condition without defect or delay.

Pharmaceutical Companies 142

Pharmaceutical Companies Pharmaceutical Companies Packaging Communication 142

Drug Topics

JANUARY 20, 2023

There are no currently approved medications for the treatment of NASH.

FDA 247

FDA 247

Fierce Healthcare

JANUARY 20, 2023

Dollar General pilots mobile clinics as it targets a bigger presence in healthcare hlandi Fri, 01/20/2023 - 18:25

140

140

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 20, 2023

The approval makes zanubrutinib available to all patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whether they are newly diagnosed or previously treated.

247

247

Pharmacy Times

JANUARY 20, 2023

Educating patients, posting on social media, and countering misinformation are critical strategies.

139

139

Pharmacy Times

JANUARY 20, 2023

Carina Dolan, PharmD, BCOP, senior director for Clinical Oncology and Pharmaceutical Outcomes at Vizient Inc, discusses the highlights and big picture moving forward for hospitals and health-system pharmacies.

Hospitals 131

Hospitals 131

Drug Topics

JANUARY 20, 2023

Highly effective medications for severe disease are expensive and administered invasively, while the development of treatments for milder disease has lagged, a new review on psoriasis clinical trials concludes.

247

247

Fierce Healthcare

JANUARY 20, 2023

Employers should carefully weigh benefits of high-deductible health plans: study fdiamond Fri, 01/20/2023 - 07:19

131

131

Drug Topics

JANUARY 20, 2023

New legislation removes what many perceived as a barrier to treating opioid use disorder.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaVoice

JANUARY 20, 2023

The first-time CEO is tapping into decades of operational expertise to help bring real-world data into the mainstream.

130

130

Fierce Healthcare

JANUARY 20, 2023

New Blues network spinout Lucet aims to simplify mental health benefits for payers pminemyer Fri, 01/20/2023 - 15:28

128

128

Pharmacy Times

JANUARY 20, 2023

Dental opioid prescriptions are associated with risk of addiction and overdose, but most states are enacting policies that limit the duration of prescriptions for acute pain.

123

123

Fierce Healthcare

JANUARY 20, 2023

Iterative Health, Gastro Health partner over AI-enabled GI care and precision medicine R&D aburky Fri, 01/20/2023 - 13:55

127

127

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 20, 2023

This is the first indication for tucatinib that extends beyond the treatment of advanced unresectable or metastatic HER2-positive breast cancer.

FDA 123

FDA 123

European Pharmaceutical Review

JANUARY 20, 2023

Two marketing authorisations for BRUKINSA ® (zanubrutinib) have been granted in Great Britain by the Medicines and Healthcare products Regulatory Agency (MHRA). The indications are for adults with chronic lymphocytic leukaemia (CLL) and for adults with marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based therapy. The MHRA’s authorisation is significant “… as there is no targeted treatment currently authorised for MZL patients other than chemoimmunotherapy

Labelling 119

Labelling Hospitals 119

Pharmacy Times

JANUARY 20, 2023

Sarah McDonald, cancer survivor and author of The Cancer Channel, discusses her experience battling 2 different unrelated cancers and the value oncology pharmacists could have provided with a greater presence on her care team.

123

123

Fierce Pharma

JANUARY 20, 2023

JPM23: Pfizer, Moderna and more look to combine COVID and flu vaccine markets zbecker Fri, 01/20/2023 - 14:48

Vaccines 119

Vaccines 119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 20, 2023

Inequities were also apparent between those who saw and did not see neurologists, analysis shows.

123

123

Fierce Healthcare

JANUARY 20, 2023

Increased Cyber Budget Calls for Healthcare to Invest in Digital Identity jpiatt Fri, 01/20/2023 - 14:38

111

111

Pharmacy Times

JANUARY 20, 2023

Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.

123

123

Drug Store News

JANUARY 20, 2023

​​​​​​​A study in the New England Journal of Medicine showed that pharmacies can offer a safe and accessible treatment starting point for patients with opioid-use disorder and keep them better engaged.

106

106

Fierce Healthcare

JANUARY 20, 2023

Aledade, Mark Cuban's drug company and a handful of others are public benefit corporations. Could it be the Rx to improve healthcare?

105

105

pharmaphorum

JANUARY 20, 2023

Leela Barham argues that the latest operational guidance for the NHS in England continues to illustrate a disconnect between the messages in big-ticket policy documents from the central government and the messages from the NHS in England on medicines. With a successor for the 2019 Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) being negotiated and a refresh of the NHS Long-Term Plan being on the to-do list for 2023, there is a chance for more alignment.

Documentation 105

Documentation Hospitals 105

Drug Store News

JANUARY 20, 2023

The settlement with Walgreens brings the total West Virginia amount brought in from opioid litigation to more than $950 million.

103

103

Fierce Pharma

JANUARY 20, 2023

Martin Shkreli runs afoul of FTC for potentially skirting lifetime pharmaceutical industry ban fkansteiner Fri, 01/20/2023 - 15:34

103

103

STAT

JANUARY 20, 2023

In an attempt to tackle the root causes of inflated insulin prices, the state of California filed a lawsuit last week accusing drug manufacturers and pharmacy benefit managers of artificially and illegally jacking up the price of insulin. The sausage-making of how insulin is priced is not for the faint of heart. It’s a complex tangle of drug manufacturers who’ve been resisting generics , health insurance companies trying to keep up impressive profits , plus the wholesalers who dist

Health Insurance Companies 103

Health Insurance Companies Insurance 103

Fierce Pharma

JANUARY 20, 2023

Ipsen's Onivyde proves its worth in aggressive pancreatic cancer zbecker Fri, 01/20/2023 - 10:48

101

101

STAT

JANUARY 20, 2023

The U.S. Federal Trade Commission asked a federal judge to hold “pharma bro” Martin Shkreli in contempt for failing to provide the agency with information needed to determine whether he is violating an order that permanently banned him from working in the pharmaceutical industry. In a motion filed federal court in New York, the FTC and seven state regulators argued that Shkreli has failed to comply with their requests to provide documents and sit for an interview as part of their i

Documentation 98

Documentation 98

The Checkup by Singlecare

JANUARY 20, 2023

Chances are, you’ve taken a generic or authorized generic medication, and for good reason—according to the U.S. Food and Drug Administration (FDA), generic medications cost 80%-85% less than brand-name drugs. An estimated 90% of prescriptions filled in the United States are for commonly prescribed generic drugs. Examples include lisinopril for high blood pressure , levothyroxine for hypothyroidism , atorvastatin for high cholesterol , Type 2 diabetes medications like metformin , and others.

Prescription Filling 98

Prescription Filling Dosage FDA Labelling 98

STAT

JANUARY 20, 2023

On Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology. This column is adapted from a new STAT report , “Targeting cancer: the new frontier of immunotherapy and precision oncology.” Scientists working to produce immunotherapies for solid tumor cancers have spent decades searching for biological targets that can help them distinguish between healthy cells and cancerous ones.

98

98

Drug Store News

JANUARY 20, 2023

Last year, Dr. Lauren F. Lyles-Stolz, PharmD joined the staff of the National Association of Chain Drug Stores as senior director of reimbursement, innovation and advocacy.

98

98

STAT

JANUARY 20, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still in the works. For now, we expect to engage in our usual ritual of promenading with the official mascot, take a drive in the countryside with the radio turned up, and hold another listening party with Mrs.

FDA 98

FDA 98